275 related articles for article (PubMed ID: 19046922)
1. NF-kappaB modulators in osteolytic bone diseases.
Xu J; Wu HF; Ang ES; Yip K; Woloszyn M; Zheng MH; Tan RX
Cytokine Growth Factor Rev; 2009 Feb; 20(1):7-17. PubMed ID: 19046922
[TBL] [Abstract][Full Text] [Related]
2. Role of nuclear factor-kappaB in the immune system and bone.
Jimi E; Ghosh S
Immunol Rev; 2005 Dec; 208():80-7. PubMed ID: 16313342
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of IKK activation, through sequestering NEMO, blocks PMMA-induced osteoclastogenesis and calvarial inflammatory osteolysis.
Clohisy JC; Yamanaka Y; Faccio R; Abu-Amer Y
J Orthop Res; 2006 Jul; 24(7):1358-65. PubMed ID: 16705717
[TBL] [Abstract][Full Text] [Related]
4. Signalling, inflammation and arthritis: NF-kappaB and its relevance to arthritis and inflammation.
Simmonds RE; Foxwell BM
Rheumatology (Oxford); 2008 May; 47(5):584-90. PubMed ID: 18234712
[TBL] [Abstract][Full Text] [Related]
5. Role of the NF-kappaB axis in immune modulation of osteoclasts and bone loss.
Abu-Amer Y; Darwech I; Otero J
Autoimmunity; 2008 Apr; 41(3):204-11. PubMed ID: 18365833
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin: tool and target for intracellular NF-kappaB inhibitors.
Wullaert A; Heyninck K; Janssens S; Beyaert R
Trends Immunol; 2006 Nov; 27(11):533-40. PubMed ID: 16982211
[TBL] [Abstract][Full Text] [Related]
7. Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation.
Tsuji-Naito K
Bioorg Med Chem; 2008 Oct; 16(20):9176-83. PubMed ID: 18823786
[TBL] [Abstract][Full Text] [Related]
8. NF-kappaB functions in osteoclasts.
Soysa NS; Alles N
Biochem Biophys Res Commun; 2009 Jan; 378(1):1-5. PubMed ID: 18992710
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand.
Wilson TJ; Nannuru KC; Futakuchi M; Sadanandam A; Singh RK
Cancer Res; 2008 Jul; 68(14):5803-11. PubMed ID: 18632634
[TBL] [Abstract][Full Text] [Related]
10. NF-kappaB and inflammation in genetic disease.
Sebban H; Courtois G
Biochem Pharmacol; 2006 Oct; 72(9):1153-60. PubMed ID: 16965764
[TBL] [Abstract][Full Text] [Related]
11. Caffeic acid phenethyl ester inhibits osteoclastogenesis by suppressing NF kappaB and downregulating NFATc1 and c-Fos.
Ha J; Choi HS; Lee Y; Lee ZH; Kim HH
Int Immunopharmacol; 2009 Jun; 9(6):774-80. PubMed ID: 19285574
[TBL] [Abstract][Full Text] [Related]
12. Disruption of ubiquitin-mediated processes in diseases of the brain and bone.
Layfield R; Searle MS
Biochem Soc Trans; 2008 Jun; 36(Pt 3):469-71. PubMed ID: 18481983
[TBL] [Abstract][Full Text] [Related]
13. Thymulin and zinc (Zn2+)-mediated inhibition of endotoxin-induced production of proinflammatory cytokines and NF-kappaB nuclear translocation and activation in the alveolar epithelium: unraveling the molecular immunomodulatory, anti-inflammatory effect of thymulin/Zn2+ in vitro.
Haddad JJ
Mol Immunol; 2009 Dec; 47(2-3):205-14. PubMed ID: 19850345
[TBL] [Abstract][Full Text] [Related]
14. (-)-Epigallocatechin gallate inhibition of osteoclastic differentiation via NF-kappaB.
Lin RW; Chen CH; Wang YH; Ho ML; Hung SH; Chen IS; Wang GJ
Biochem Biophys Res Commun; 2009 Feb; 379(4):1033-7. PubMed ID: 19150340
[TBL] [Abstract][Full Text] [Related]
15. TRAF6 negatively regulates TNFalpha-induced NF-kappaB activation.
Funakoshi-Tago M; Kamada N; Shimizu T; Hashiguchi Y; Tago K; Sonoda Y; Kasahara T
Cytokine; 2009 Feb; 45(2):72-9. PubMed ID: 19091594
[TBL] [Abstract][Full Text] [Related]
16. The role of ubiquitin in NF-kappaB regulatory pathways.
Skaug B; Jiang X; Chen ZJ
Annu Rev Biochem; 2009; 78():769-96. PubMed ID: 19489733
[TBL] [Abstract][Full Text] [Related]
17. The nitrosylated flurbiprofen derivative HCT1026 inhibits cytokine-induced signalling through a novel mechanism of action.
Idris AI; Ralston SH; van't Hof RJ
Eur J Pharmacol; 2009 Jan; 602(2-3):215-22. PubMed ID: 19046964
[TBL] [Abstract][Full Text] [Related]
18. The nuclear factor-kappaB (NF-kappaB): from a versatile transcription factor to a ubiquitous therapeutic target.
Yates LL; Górecki DC
Acta Biochim Pol; 2006; 53(4):651-62. PubMed ID: 17068636
[TBL] [Abstract][Full Text] [Related]
19. The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1.
Jung WK; Park IS; Park SJ; Yea SS; Choi YH; Oh S; Park SG; Choi IW
Life Sci; 2009 Jul; 85(1-2):46-53. PubMed ID: 19409914
[TBL] [Abstract][Full Text] [Related]
20. Targeting NF-kappaB: a promising molecular therapy in inflammatory arthritis.
Roman-Blas JA; Jimenez SA
Int Rev Immunol; 2008; 27(5):351-74. PubMed ID: 18853343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
